This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Researchers Report New Zika Complication
    Dr. John England, professor and chair of neurology at LSU Health New Orleans School of Medicine, and colleagues in Honduras and Venezuela have reported a new neurological complication of infection with the Zika virus. They described the first confirmed case of ...More
    Yesterday Posted in News
  • HHS Funds Development of Zika Diagnostic Test for Use in Doctors' Offices
    A test that could provide a Zika diagnosis for patients less than 30 minutes in doctors’ and other healthcare providers’ offices is moving forward with funding from the U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary ...More
    Yesterday Posted in News
  • FDA Advises Testing for Zika Virus in All Donated Blood and Blood Components in the US
    As a further safety measure against the emerging Zika virus outbreak, today the Food and Drug Administration (FDA) issued a revised guidance recommending universal testing of donated whole blood and blood components for Zika virus in the U.S. and its territories. ...More
    Yesterday Posted in News
  • Understanding the Likely Causes of Zika Virus Congenital Syndrome
    The ongoing Zika virus epidemic in the Americas and the observed association with both fetal abnormalities (primary microcephaly) and adult autoimmune pathology (Guillain–Barré syndrome) has brought attention to this neglected pathogen. In “Zika Fetal ...More
    Yesterday Posted in News
  • Shortwave Infrared Instrument from MIT Could See Deeper, Help Improve Diagnosis of Ear Infections
    A new device developed by researchers at MIT and a physician at Connecticut Children's Medical Center could greatly improve doctors' ability to accurately diagnose ear infections. That could drastically reduce the estimated 2 million cases per year in the United States ...More
    Yesterday Posted in News
  • Scientists Grow Noroviruses in Human Intestinal Cell Cultures
    Human norovirus particles were released into the supernatant of infected cultures and detected with electron microscopy. Courtesy of Estes Lab.   Human noroviruses, the leading viral cause of acute diarrhea around the world, have been difficult to study because ...More
    Yesterday Posted in News
  • Fighting Penicilliosis
    Penicilliosis, caused by the fungus Talaromyces marneffei, is a major opportunistic infection in Southeast Asia. A study published in PLOS Neglected Tropical Diseases reports that the fungal protein Mp1p is responsible for the pathogen's ability to cause disease in mice, ...More
    2 days ago Posted in News
  • Pfizer to Acquire Small Molecule Anti-Infective Business From AstraZeneca
    Pfizer Inc. announces that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, primarily outside the United States. The agreement includes the commercialization ...More
    2 days ago Posted in News
  • New Strategy to Fight Mosquitoes in a More Efficient and Sustainable Way
    Mosquitoes continue to build resistance to existing pesticides. Research has now shown that the chemical substances emitted by one of the mosquito's natural enemies - the backswimmer - makes the biological pesticide Bti more deadly. These so-called predator cues also impair ...More
    2 days ago Posted in News
  • Key Substance for Treatment of Visceral Leishmaniasis Identified
    A study shows that stimulating the production of interleukin-17A (IL-17A), one of the cytokines released by cells of the immune system, can be an effective strategy for the treatment of visceral leishmaniasis, considered one of the six most important parasitic diseases ...More
    2 days ago Posted in News